AAAAAA

   
Results: 1-11 |
Results: 11
PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN
Authors: LIEBES L POTMESIL M KIM T PEASE D BUCKLEY M FRY D CHO J ADLER H DAR K ZELENIUCHJACQUOTTE A HOCHSTER H
Citation: L. Liebes et al., PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN, Clinical cancer research, 4(3), 1998, pp. 545-557
PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN
Authors: LIEBES L POTMESIL M KIM T PEASE D BUCKLEY M FRY D CHO J ADLER H DAR K ZELENIUCHJACQUOTTE A HOCHSTER H
Citation: L. Liebes et al., PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN, Clinical cancer research, 4(3), 1998, pp. 545-557
ANTI-ANGIOGENIC EFFECTS OF 9-AMINO-20(S)-CAMPTOTHECIN (9AC), TOPOTECAN (TTN), AND CAMPTOSAR (CPT-11)
Authors: OLEARY JJ SHAPIRO RL REN CJ CHUANG N COHEN HW MUGGIA F POTMESIL M
Citation: Jj. Oleary et al., ANTI-ANGIOGENIC EFFECTS OF 9-AMINO-20(S)-CAMPTOTHECIN (9AC), TOPOTECAN (TTN), AND CAMPTOSAR (CPT-11), Annals of oncology, 9, 1998, pp. 296-296
MAPS ALIVE - VIEWING GEOSPATIAL INFORMATION ON THE WWW
Authors: POTMESIL M
Citation: M. Potmesil, MAPS ALIVE - VIEWING GEOSPATIAL INFORMATION ON THE WWW, Computer networks and ISDN systems, 29(8-13), 1997, pp. 1327-1342
DRUG-INDUCED APOPTOSIS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RELATIONSHIP BETWEEN P53 GENE MUTATION AND BCL-2 BAX PROTEINS IN DRUG-RESISTANCE/
Authors: THOMAS A ELROUBY S REED JC KRAJEWSKI S SILBER R POTMESIL M NEWCOMB EW
Citation: A. Thomas et al., DRUG-INDUCED APOPTOSIS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RELATIONSHIP BETWEEN P53 GENE MUTATION AND BCL-2 BAX PROTEINS IN DRUG-RESISTANCE/, Oncogene, 12(5), 1996, pp. 1055-1062
GROWTH-INHIBITION OF HUMAN CANCER METASTASES BY CAMPTOTHECINS IN NEWLY DEVELOPED XENOGRAFT MODELS
Authors: POTMESIL M VARDEMAN D KOZIELSKI AJ MENDOZA J STEHLIN JS GIOVANELLA BC
Citation: M. Potmesil et al., GROWTH-INHIBITION OF HUMAN CANCER METASTASES BY CAMPTOTHECINS IN NEWLY DEVELOPED XENOGRAFT MODELS, Cancer research, 55(23), 1995, pp. 5637-5641
FREQUENT HOMOZYGOUS DELETIONS OF D13S218 ON 13Q14 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA INDEPENDENT OF DISEASE STAGE AND RETINOBLASTOMA GENE INACTIVATION
Authors: NEWCOMB EW THOMAS A SELKIRK A LEE SY POTMESIL M
Citation: Ew. Newcomb et al., FREQUENT HOMOZYGOUS DELETIONS OF D13S218 ON 13Q14 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA INDEPENDENT OF DISEASE STAGE AND RETINOBLASTOMA GENE INACTIVATION, Cancer research, 55(10), 1995, pp. 2044-2047
CAMPTOTHECINS - FROM BENCH RESEARCH TO HOSPITAL WARDS
Authors: POTMESIL M
Citation: M. Potmesil, CAMPTOTHECINS - FROM BENCH RESEARCH TO HOSPITAL WARDS, Cancer research, 54(6), 1994, pp. 1431-1439
CHEMOSENSITIVITY OF LYMPHOCYTES FROM PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA TO CHLORAMBUCIL, FLUDARABINE, AND CAMPTOTHECIN ANALOGS
Authors: SILBER R DEGAR B COSTIN D NEWCOMB EW MANI M ROSENBERG CR MORSE L DRYGAS JC CANELLAKIS ZN POTMESIL M
Citation: R. Silber et al., CHEMOSENSITIVITY OF LYMPHOCYTES FROM PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA TO CHLORAMBUCIL, FLUDARABINE, AND CAMPTOTHECIN ANALOGS, Blood, 84(10), 1994, pp. 3440-3446
P53 GENE MUTATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS ASSOCIATED WITH DRUG-RESISTANCE AND IS INDEPENDENT OF MDR1 MDR3 GENE-EXPRESSION/
Authors: ELROUBY S THOMAS A COSTIN D ROSENBERG CR POTMESIL M SILBER R NEWCOMB EW
Citation: S. Elrouby et al., P53 GENE MUTATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS ASSOCIATED WITH DRUG-RESISTANCE AND IS INDEPENDENT OF MDR1 MDR3 GENE-EXPRESSION/, Blood, 82(11), 1993, pp. 3452-3459
IN-VITRO SENSITIVITY TO CAMPTOTHECINS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH AND WITHOUT P53-GENE MUTATION
Authors: COSTIN D POTMESIL M NEWCOMB EW ELROUBY S THOMAS A DRYGAS J MORSE L SILBER R
Citation: D. Costin et al., IN-VITRO SENSITIVITY TO CAMPTOTHECINS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH AND WITHOUT P53-GENE MUTATION, Blood, 82(10), 1993, pp. 10000043-10000043
Risultati: 1-11 |